Loading...
935106861
info@markelab.com
Precio
375€ (100 µg)
Suvratoxumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Staphylococcus aureus Alpha Toxin, Suvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).
Biosimilars
Human
Monoclonal
Human
Staphylococcus aureus Alpha Toxin
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1629620-18-3
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más